SFC Capital

AMPED is a biotechnology company that specializes in the production of polymerase chain reaction (PCR) reagents. Its mission is to make PCR technology more accessible and affordable to scientists and innovators. AMPED achieves this by offering high-quality PCR reagents that outperform industry standards at a significantly lower cost. The company's approach includes distributed manufacturing and integrated automation, which further enhance affordability and accessibility.

LaennecAI is a clinical AI company specializing in chronic disease management solutions. It has developed a medical device, a digital stethoscope, which transforms modern smartphones into powerful diagnostic tools. The company's technology enables precise monitoring and analysis of respiratory and cardiac sounds, facilitating telemedicine, remote patient monitoring, and virtual wards. This ensures patients receive in-depth, reliable analysis and continuous care.

Mulder specializes in blockchain-based traceability solutions for the medical device industry. It develops a network platform that offers real-time visibility and traceability across the entire supply chain, from raw material sourcing to patient application. This enables healthcare providers and manufacturers to verify device provenance, ensure compliance, and enhance patient safety.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Vesynta is a medical technology company that specializes in individualizing drug therapy through its innovative blood monitoring platform. The company’s technology integrates drug monitoring hardware with precision dosing software to create a universal bedside platform aimed at evidence-based clinical decision support. By utilizing robotic automation, analytical software, and machine learning, Vesynta's system determines a patient's drug exposure, empowering healthcare providers to make data-driven decisions. This approach facilitates the personalization of drug dosages, ultimately enhancing treatment outcomes while minimizing side effects for patients.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

AMPED is a biotechnology company that specializes in the production of polymerase chain reaction (PCR) reagents. Its mission is to make PCR technology more accessible and affordable to scientists and innovators. AMPED achieves this by offering high-quality PCR reagents that outperform industry standards at a significantly lower cost. The company's approach includes distributed manufacturing and integrated automation, which further enhance affordability and accessibility.

RegMetrics is a developer of a medical device regulatory tool aimed at assisting health technology innovators in navigating complex medical device regulations. The company's platform leverages data-driven technologies to streamline the understanding of these regulations, making it quicker and easier for users to comply with the necessary requirements in the medical device landscape. By providing innovative solutions, RegMetrics helps facilitate the regulatory process for companies involved in the development of health technologies.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

PulmoBioMed is a company focused on providing innovative solutions for clinicians and researchers through non-invasive sampling of fluids. The firm has developed a passive fluid aerosol sampler designed to capture exhaled breath condensate and aerosol samples. This product effectively segregates exhaled and environmental particles by size, addressing critical challenges such as sample contamination and loss. PulmoBioMed's technology aims to generate highly reproducible data with precise digital molecular analysis, facilitating the study of biological agents and supporting metabolomic profiling. Through its advancements, the company seeks to enhance research capabilities and improve patient outcomes in the field of respiratory health.

Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

OSSTEC specializes in advanced orthopedic implants, focusing on knee replacement surgeries. Its metal 3D printed implants mimic natural bone structure, reducing stress shielding, promoting bone ingrowth, and enhancing long-term implant stability for patients with osteoarthritis.

Pinpoint Molecular develops point-of-care solutions for detecting infectious diseases. Based in London, it offers diagnostic kits and laboratory services.

Figura Analytics develops a nanotechnology platform that rapidly characterizes, identifies, and quantifies particles in liquids using nanopore technology. The system integrates preparatory microfluidics, sensors, and software algorithms to recognize particles suspended in any solution, regardless of size or sample matrix, enabling medical professionals to act quickly and manufacturers to adjust production earlier. The platform supports applications across fields such as diagnostic testing and beverage analysis, helping improve product consistency and quality control by delivering rapid, actionable particle data.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

BBL Protect specializes in the development of medical devices and solutions aimed at enhancing the safe transportation of patients with infectious diseases or contaminants. The company focuses on creating patient transfer systems that prioritize infection control, ensuring the protection of patients, healthcare staff, and the surrounding environment. By delivering innovative products that emphasize safety and functionality, BBL Protect enables healthcare service providers to achieve higher standards in infection control within hospitals and emergency vehicles, thereby improving overall safety and practicality in patient transfer scenarios.

Elaitra develops AI-driven breast cancer diagnostic tools. Their platform includes a voice-based patient engagement system powered by Generative LLM and an AI reading tool for 3D X-rays, approved by FDA and UK regulators.

Healome Therapeutics specializes in developing treatments for ocular surface diseases. The company creates innovative 'pro-healing' microenvironments to address complex conditions, overcoming biological, chemical, and physical challenges.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Figura Analytics develops a nanotechnology platform that rapidly characterizes, identifies, and quantifies particles in liquids using nanopore technology. The system integrates preparatory microfluidics, sensors, and software algorithms to recognize particles suspended in any solution, regardless of size or sample matrix, enabling medical professionals to act quickly and manufacturers to adjust production earlier. The platform supports applications across fields such as diagnostic testing and beverage analysis, helping improve product consistency and quality control by delivering rapid, actionable particle data.

4D Medicine specializes in creating innovative solutions for the targeted and controlled regeneration of human tissue through the development of degradable, implantable medical devices. Utilizing novel photopolymer materials, the company is advancing a range of products that are currently undergoing regulatory clearance with the Food and Drug Administration. These resorbable medical devices aim to enhance patient outcomes in various applications, including musculoskeletal surgery, soft tissue repair, and drug delivery. By focusing on regulatory approval and effective medical applications, 4D Medicine seeks to provide valuable options for medical device suppliers and healthcare providers.

Analytic Health provides a data-driven insights to healthcare companies that helps people to have access to medicines.

Medtech

Algocyte is a UK-based company that specializes in providing comprehensive, medically-driven solutions for remote blood testing and health monitoring. The company enables healthcare professionals to remotely track and assess patients with various conditions, including cancer, anemia, and autoimmune disorders. Algocyte's innovative medical device conducts a wide range of hematological and biochemical tests, allowing for continuous health monitoring. By analyzing collected data over time, Algocyte generates detailed health profiles that offer a more accurate understanding of an individual's health status compared to traditional single-snapshot assessments.

Curamicus Ltd is a healthcare technology company based in Polegate, United Kingdom, founded in 2015. Formerly known as Hip Buddy Ltd, the company specializes in developing wearable devices that utilize sensors, artificial intelligence, and cloud technology to identify anxiety and vulnerability in elderly individuals. By creating massively scalable assistive technology, Curamicus aims to enhance the quality of life for elders and vulnerable populations, enabling them to live safer and more fulfilling lives. The focus of Curamicus is on personalized wellness solutions that effectively manage anxiety and improve overall well-being for its users.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

FindMe Health is an online platform designed to empower patients by providing access to reliable and comparable information on the quality and pricing of healthcare services. Targeting individuals who are seeking alternatives to NHS treatment, especially when they are ineligible or facing long waiting times, the platform allows users to compare hospital consultants based on various criteria such as procedure volume, patient feedback, hospital location, and treatment costs. This comprehensive comparison helps patients make informed decisions regarding their healthcare options. In addition to offering detailed insights on conditions, hospitals, and consultants, FindMe Health facilitates the booking of initial consultations directly through the site. By consolidating essential information in one place, it aims to simplify the often confusing landscape of self-pay healthcare and enable patients to take control of their health decisions.

Performr.ai is a Biotechnology Research firm offering monitoring and body sensors for personalised health and insights.

Graphene Trace is a healthcare technology company that specializes in preventing pressure ulcers, a common issue among wheelchair users and hospital patients. The company's core product is a smart, pressure-sensing fabric that continuously monitors pressure distribution, alerting users and caregivers in real-time to repositioning needs. This innovative solution enables early intervention, preventing pressure ulcers, and ensuring user comfort and affordability.

SNIP Medical is a medical devices manufacturer specializing in tongue-tie correction. It produces a unique frenotomy device designed to enhance safety and reproducibility in procedures, allowing healthcare providers to treat tongue-tied infants at the point of care.